Last reviewed · How we verify

polyethylene glycol +Bisacodyl

Medical University of Warsaw · FDA-approved active Small molecule

polyethylene glycol +Bisacodyl is a Combination laxative (osmotic + stimulant) Small molecule drug developed by Medical University of Warsaw. It is currently FDA-approved for Bowel cleansing prior to colonoscopy or other gastrointestinal procedures, Constipation management. Also known as: Polyethylene glycol: Fortrans.

Polyethylene glycol acts as an osmotic laxative to draw water into the bowel, while bisacodyl stimulates colonic muscle contractions to promote bowel evacuation.

Polyethylene glycol acts as an osmotic laxative to draw water into the bowel, while bisacodyl stimulates colonic muscle contractions to promote bowel evacuation. Used for Bowel cleansing prior to colonoscopy or other gastrointestinal procedures, Constipation management.

At a glance

Generic namepolyethylene glycol +Bisacodyl
Also known asPolyethylene glycol: Fortrans
SponsorMedical University of Warsaw
Drug classCombination laxative (osmotic + stimulant)
ModalitySmall molecule
Therapeutic areaGastroenterology
PhaseFDA-approved

Mechanism of action

Polyethylene glycol (PEG) is a non-absorbable osmotic agent that increases stool water content and volume, facilitating bowel movement. Bisacodyl is a stimulant laxative that directly irritates the colonic mucosa and increases peristalsis. Together, they provide both osmotic and mechanical promotion of defecation, commonly used for bowel cleansing prior to diagnostic or surgical procedures.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about polyethylene glycol +Bisacodyl

What is polyethylene glycol +Bisacodyl?

polyethylene glycol +Bisacodyl is a Combination laxative (osmotic + stimulant) drug developed by Medical University of Warsaw, indicated for Bowel cleansing prior to colonoscopy or other gastrointestinal procedures, Constipation management.

How does polyethylene glycol +Bisacodyl work?

Polyethylene glycol acts as an osmotic laxative to draw water into the bowel, while bisacodyl stimulates colonic muscle contractions to promote bowel evacuation.

What is polyethylene glycol +Bisacodyl used for?

polyethylene glycol +Bisacodyl is indicated for Bowel cleansing prior to colonoscopy or other gastrointestinal procedures, Constipation management.

Who makes polyethylene glycol +Bisacodyl?

polyethylene glycol +Bisacodyl is developed and marketed by Medical University of Warsaw (see full Medical University of Warsaw pipeline at /company/medical-university-of-warsaw).

Is polyethylene glycol +Bisacodyl also known as anything else?

polyethylene glycol +Bisacodyl is also known as Polyethylene glycol: Fortrans.

What drug class is polyethylene glycol +Bisacodyl in?

polyethylene glycol +Bisacodyl belongs to the Combination laxative (osmotic + stimulant) class. See all Combination laxative (osmotic + stimulant) drugs at /class/combination-laxative-osmotic-stimulant.

What development phase is polyethylene glycol +Bisacodyl in?

polyethylene glycol +Bisacodyl is FDA-approved (marketed).

What are the side effects of polyethylene glycol +Bisacodyl?

Common side effects of polyethylene glycol +Bisacodyl include Abdominal cramping, Nausea, Bloating, Diarrhea, Vomiting.

Related